Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients

Total article views   Abstract views HTML views PDF downloads Totals
5,302 Dovepress* 3,382 629+ 1,573 4,011
PubMed Central* 0 1,291 312 1,291
Totals 3,382 1,920 1,885 5,302
*Since 31 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar